KAMRF yields 1818.18% · PFE yields 6.13%● Live data
📍 KAMRF pulled ahead of the other in Year 1
Combined, KAMRF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KAMRF + PFE for your $10,000?
Kalamazoo Resources Limited explores for and develops gold and base metal properties in Australia. The company also explores for nickel and cobalt deposits. It holds interests in the Castlemaine project that consists of three exploration licenses covering an area of approximately 310 square kilometers; the South Muckleford project that comprises an area of approximately 161 square kilometers; the Tarnagulla project; and the Myrtle project located in Victoria. The company also holds interests in the Pilbara projects, including the Ashburton project comprising 4 mining leases and 3 exploration licenses covering an area of approximately 217 square kilometers; the DOM's Hill project that covers an area of approximately 125 square kilometers; the Marble Bar project covering an area of approximately 125 square kilometers; the Pear Creek lithium project covering an area of approximately 147 square kilometers; and the Sisters project covering an area of approximately 239 square kilometers situated in Western Australia. Kalamazoo Resources Limited was incorporated in 2011 and is headquartered in West Perth, Australia.
Full KAMRF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.